SHAC SCP & CO Healthcare Acquisition
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 11, 2021
SCP & CO Healthcare Acquisition Company
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
2909 W Bay to Bay Blvd., Suite 300
Tampa, FL 33629
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (813) 318-9600
(Former name or former address, if changed since last report)
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange
on which registered
|Units, each consisting of one share of Class A Common Stock, par value $0.0001 per share, and one-half of one Redeemable Warrant||SHACU||The Nasdaq Stock Market LLC|
|Shares of Class A Common Stock, par value $0.0001 per share, included as part of the units||SHAC||The Nasdaq Stock Market LLC|
|Redeemable Warrants included as part of the units||SHACW||The Nasdaq Stock Market LLC|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
Item 8.01. Other Events.
Separate Trading of Units, Class A Common Stock and Warrants
On March 11, 2021, SCP & CO Healthcare Acquisition Company (the “Company”) issued a press release, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K, announcing that, commencing on March 15, 2021, the holders of units issued in its initial public offering (the “Units”), each consisting of one share of Class A common stock of the Company, par value $0.0001 per share (the “Class A Common Stock”), and one-half of one warrant of the Company (“Warrant”), with each whole Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share, may elect to separately trade the shares of Class A Common Stock and Warrants included in the Units. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The shares of Class A Common Stock and the Warrants are expected to trade on the Nasdaq Capital Market under the symbols “SHAC” and “SHACW,” respectively. The Units not separated will continue to trade on the Nasdaq Capital Market under the symbol “SHACU.” Holders of Units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the Units into shares of Class A Common Stock and Warrants.
Item 9.01 Financial Statements and Exhibits.
|99.1||Press Release, dated March 11, 2021|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|SCP & CO Healthcare Acquisition Company|
/s/ Scott Feuer
|Name: Scot Feuer|
|Title: Chief Executive Officer|
|Dated: March 11, 2021|